MedPath

Pronostic Score of Morbidity to Determine Risk of Complications After Endoscopic Submucosal Dissection for Colorectal Lesions

Completed
Conditions
Polyp of Colon
Registration Number
NCT04647266
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

The mains complications in colo-rectal dissection are the pain, the delayed bleeding and the perforation and represent around 10%.

Currently, the procedure is realized during a hospitalization with not real recommendation about the time of this.

There is currently no score established for the colo-rectal endoscopic submucosal dissection.

* To develop clinical or mixed prognostic score after endoscopic subcostal dissection for colorectal lesions in Nancy's hospital.

* Allow to obtain an estimation of number of patients required for a larger study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
168
Inclusion Criteria
  • Patient suffering of lesion relevant of endoscopic submucosal dissection treatment:
  • Lesions for which en bloc resection with snare EMR is difficult to apply i/LST-NG, particularly LST-NG (PD) ii/ Lesions showing a VI-type pit pattern iii/ Carcinoma with shallow T1 (SM) invasion Large depressed-type tumors iv/ Large protruded-type lesions suspected to be carcinoma
  • Mucosal tumors with submucosal fibrosis
  • Sporadic tumors in conditions of chronic inflammation such as ulcerative colitis
  • Local residual or recurrent early carcinomas after endoscopic resection Local res Les lésions de plus
  • Male or female patients aged ≥ 18 years old
  • Patients able to fill in questionnaires written in French
Exclusion Criteria
  • Suspicion of deep submucosal cancer by analysis of macroscopic appearance (Paris O-III), vascular pattern and pit pattern (SANO IIIB, KUDO Vn)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To develop clinical or mixed prognostic score after endoscopic subcostal dissection for colorectal lesions in Nancy's hospital.From 2016 to 2020
Secondary Outcome Measures
NameTimeMethod
Allow to obtain an estimation of number of patients required for a larger studyFrom 2016 to 2020

Trial Locations

Locations (1)

CHRU Brabois

🇫🇷

Nancy, Meurthe ET Moselle, France

© Copyright 2025. All Rights Reserved by MedPath